An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P169
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ribrag, Vincent
Armand, Phillippe
Kuruvilla, John
Michot, Jean-Marie
Moskowitz, Craig H
Marinello, Patricia
Snyder, Ellen
Balakumaran, Arun
Shipp, Margaret A
Zinzani, Pier Luigi
Article History
First Online: 4 November 2015